Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EXEDRA

Financiado

Cerrado

EXpansion of the European Joint Programming Initiative on Drug Resistance to Ant...

EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials EXEDRA, an EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials, will build on, and further support the structure and activities of JPIAMR to address the two major objectives of HCO-04-2016 t... ver más

31/12/2021

VETENSKAPSRADET S...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

VETENSKAPSRADET SWEDISH RESEARCH COUNCIL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 17 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-12-31

SC1-HCO-04-2016: Towards globalisation of the Joint...

I+D

Cerrada hace 8 años

0% 96% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

17 Participantes

VETENSKAPSRADET SWEDISH RES...

1.26M€ | Lider

ZED WORLDWIDE

678.43K€ | Participante

UKRI

27.50K€ | Participante

MINISTERE DE L'ENSEIGNEMENT...

81.25K€ | Participante

Proyectos interesantes

TIPAT

Medical Technol...

Data Science

4M€ Cerrado

PID2019-108643GA-I00

Medical Technol...

Data Science

85K€ Cerrado

COMBINE

Medical Technol...

Data Science

25M€ Cerrado

COMBACTE-NET

Medical Technol...

Data Science

221M€ Cerrado

JPIAMR

Medical Technol...

Data Science

2M€ Cerrado

COMBACTE-NET

Medical Technol...

Data Science

221M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 60 meses Fecha Inicio: 2016-12-05
Fecha Fin: 2021-12-31

Líder del proyecto

VETENSKAPSRADET SWEDISH RESEARCH COUNCIL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto EXEDRA, an EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials, will build on, and further support the structure and activities of JPIAMR to address the two major objectives of HCO-04-2016 topic: extending JPIAMR globally and creating a long-term sustainable structure for future expansion and governance which will coordinate national funding and collaborative actions supporting the implementation of the JPIAMR Strategic Research Agenda (SRA). JPIAMR EXEDRA will be the second Coordinated Support Action (CSA) for this Joint Programming Initiative (JPI) and essentially build on the work of the first CSA (JPIAMR), which ended February 2016. It will provide a strong support structure for the JPIAMR during the forthcoming implementation and expansion phaseby maintaining a continuity between the objectives, tasks and Work Packages of EXEDRA and JPIAMR. Support facilitated by the CSA EXEDRA will ensure that the ethos of joint programming in the area antimicrobial drug resistance becoming embedded within JPIAMR member’s research and innovation policies and programmes. EXEDRA will have the following work packages: WP1 Management and coordination; WP2 Strategy, governance, and long term sustainability; WP3 Internationalisation and capacity extension; WP4 Alignment with policy and industry; WP5 Research alignment; WP6 Communication, dissemination, and advocacy. EXEDRA will significantly contribute to the delivery of the JPIAMR SRA combined with the JPI-EC-AMR effort and the experience of the JPIAMR members. EXEDRA (and the JPIAMR) will support transnational cooperation to to pool substantial and long-term research funding and serve to complement other initiatives in the AMR area. It will create momentum with the potential to move the frontiers forward and offer new opportunities for industry, new tools for society, and new evidence-based data for policy makers, which will inspire other necessary initiatives.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores